Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non-Small Cell Lung Cancer.
| Autor: | SHAN LI, SEGAL, EVE M. |
|---|---|
| Zdroj: | JADPRO: Journal of the Advanced Practitioner in Oncology; Mar/Apr2017, Vol. 8 Issue 2, p196-201, 6p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|